These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4623997)

  • 21. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of feto-maternal isoimmunizations. Organization in the Marseilles region].
    Nublat M; Dufour Y; Gaujoux J; Alcaraz J; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):209-11. PubMed ID: 4143444
    [No Abstract]   [Full Text] [Related]  

  • 23. [Systematic immunization in pregnancy].
    Simonetti N
    Minerva Ginecol; 1972 Feb; 24(2):98-9. PubMed ID: 4211684
    [No Abstract]   [Full Text] [Related]  

  • 24. [New information about the prevention of Rh isoimmunization].
    Tesauro G
    Minerva Ginecol; 1968 May; 20(10):847-50. PubMed ID: 4186920
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of post-transfusional feto-maternal immunizations].
    Caderas De Kerleau J; Durand C
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):230. PubMed ID: 4220062
    [No Abstract]   [Full Text] [Related]  

  • 26. Antenatal Rh prophylaxis is unnecessary for "Asia type" DEL women.
    Shao CP; Xu H; Xu Q; Sun GD; Li JP; Zhang BW; Liang XH; Liu Z; Zhou Y; Li D; Zhuang NB
    Transfus Clin Biol; 2010 Oct; 17(4):260-4. PubMed ID: 20961786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental and clinical studies on 1st transabdominal flooding of the maternal circulation with fetal erythrocytes (new aspects of Rh sensitization)].
    Hindemann P
    Geburtshilfe Frauenheilkd; 1966 Oct; 26(10):1359-72. PubMed ID: 4162573
    [No Abstract]   [Full Text] [Related]  

  • 28. Standarization of anti-D for use in the prevention of Rh sensitization.
    Hughes-Jones NC
    Prog Immunobiol Stand; 1970; 4():279-81. PubMed ID: 4992311
    [No Abstract]   [Full Text] [Related]  

  • 29. High-titer anti-D plasma for the prevention of Rh isoimmunization.
    Hamilton EG
    Obstet Gynecol; 1970 Sep; 36(3):331-40. PubMed ID: 4988960
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary clinical experiences with immunosuppressive agents in prenatal treatment of Rh isoimmunization].
    Viozzi A; Gasparini G; Cagliari P
    Minerva Ginecol; 1970 May; 22(9):462-3. PubMed ID: 4995416
    [No Abstract]   [Full Text] [Related]  

  • 31. [Critical study of the results of an application of preventive treatment taking into account the systematic evaluation of feto-maternal hemorrhage].
    Huchet J; Crégut R; Briffoteaux P; Pinon F
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):203-5. PubMed ID: 4143442
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of maternal Rh sensitization: anti-Rh immune globulin.
    Wilson WB
    J Miss State Med Assoc; 1970 Feb; 11(2):53-6. PubMed ID: 4189158
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunosuppression of anti-Rh antibodies: mechanism of action and times of administration of the anti-D immunoglobulins].
    Carretti N
    Attual Ostet Ginecol; 1968; 1():181-92. PubMed ID: 4194920
    [No Abstract]   [Full Text] [Related]  

  • 35. Remaining problems in the prevention of Rh0 isoimmunization.
    Goplerud CP
    Semin Perinatol; 1977 Apr; 1(2):177-81. PubMed ID: 89700
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of anti-Rh immunoglobulin in the prevention of isoimmunization to Rh factor].
    Medina Aguilar R
    Ginecol Obstet Mex; 1969 Jul; 26(153):47-59. PubMed ID: 4185870
    [No Abstract]   [Full Text] [Related]  

  • 37. [Usefulness of periodic and regional evaluation in prevention of Rhesus isoimmunization: remarks on North American experiences].
    Schlaeder G; Kelly A
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):207-9. PubMed ID: 4143443
    [No Abstract]   [Full Text] [Related]  

  • 38. Preventing maternal sensitization to Rho antigen.
    Alter AA; Haut IH
    N Y State J Med; 1971 Oct; 71(19):2326-7. PubMed ID: 4999308
    [No Abstract]   [Full Text] [Related]  

  • 39. [Letter: Prevention of Rh sensitization].
    Schneider J
    Dtsch Med Wochenschr; 1976 Apr; 101(15):596. PubMed ID: 816630
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contribution of specific immunoglobulin anti-D to prophylaxis of haemolytic disease of the newborn].
    Bianu V; Zervos G; Kondi V; Balan S
    Rev Fr Gynecol Obstet; 1973 Oct; 68(10):569-71. PubMed ID: 17474215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.